« Back to Record
Citation APA

Awada, A., Hendlisz, A., Gil, T., Bartholomeus, S., Mano, M. S., de Valeriola, D., Strumberg, D., Brendel, E., Haase, C. G., Schwartz, B., & Piccart-Gebhart, M. (2005). Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours. British Journal of Cancer, 92(10), 1855-1861. doi:10.1038/sj.bjc.6602584


Permalink

http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/53723

Awada, A., Hendlisz, A., Gil, T., Bartholomeus, S., Mano, M. S., de Valeriola, D., Strumberg, D., Brendel, E., Haase, C. G., Schwartz, B., & Piccart-Gebhart, M. (2005). Phase I safety and pharmacokinetics of BAY 43-9006 administered for 21 days on/7 days off in patients with advanced, refractory solid tumours. British Journal of Cancer, 92(10), 1855-1861. doi:10.1038/sj.bjc.6602584